<DOC>
	<DOCNO>NCT00222196</DOCNO>
	<brief_summary>Background : Percutaneous transluminal angioplasty ( PTA ) popularize simple , effective cheap treatment achieve 50-70 % symptomatic patency rate patient peripheral occlusive disease.. However , fact remain indication perform PTA still base opinion scientific data . The purpose trial randomize patient primarily refer intermittent claudication two group : One group offer conservative treatment ; group offer conservative treatment combine PTA . Primary outcome : The patient quality life . Secondary outcome : Pain-free walking distance ; pain-score ; death ; amputation ; change relevant biomarkers</brief_summary>
	<brief_title>Oslo Balloon Angioplasty Versus Conservative Treatment</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Age 75 year Symptoms intermittent claudication duration &gt; 3 month ABPI &lt; 0.9 A twoyear followup possible Subjective painfree walk distance &gt; 400m Critical ischemia Previous vascular endovascular surgery Diabetes ulcer Other physical disability abrogate organised exercise Use warfarin Mentally unable give inform consent Renal insufficiency Coagulation disorder Duplex PTA impossible</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Days</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>atherosclerosis</keyword>
	<keyword>quality life</keyword>
	<keyword>pain-score</keyword>
	<keyword>biomarkers</keyword>
</DOC>